BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,044 | -20.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $12,640 | +40.5% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $8,998 | +2.7% | 200 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $8,762 | -12.4% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | -52.4% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | -8.7% | 200 | -11.9% | 0.00% | 0.0% |
| Q3 2021 | $23,000 | +21.1% | 227 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $19,000 | -9.5% | 216 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |